{"id":"https://openalex.org/W7203636612","doi":"https://doi.org/10.1016/j.jpet.2026.105013","title":"Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-\u03b1 suppression","display_name":"Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-\u03b1 suppression","publication_year":2026,"publication_date":"2026-08-17","ids":{"openalex":"https://openalex.org/W7203636612","doi":"https://doi.org/10.1016/j.jpet.2026.105013","pmid":"https://pubmed.ncbi.nlm.nih.gov/42700643"},"language":"en","primary_location":{"id":"doi:10.1016/j.jpet.2026.105013","doi":"https://doi.org/10.1016/j.jpet.2026.105013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpet.2026.105013","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jpet.2026.105013","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101667588","display_name":"Ryota Hashimoto","orcid":"https://orcid.org/0000-0003-0983-6704","observed_orcids":["https://orcid.org/0000-0003-0983-6704"]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Ryota Hashimoto","raw_affiliation_strings":["Laboratory of Cell Biology, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan; Department of Physiology, Juntendo University Faculty of Medicine, Bunkyo-ku, Japan. Electronic address: hryota@juntendo.ac.jp"],"raw_orcid":"https://orcid.org/0000-0003-0983-6704","affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan; Department of Physiology, Juntendo University Faculty of Medicine, Bunkyo-ku, Japan. Electronic address: hryota@juntendo.ac.jp","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147348585","display_name":"Yaojia Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yaojia Wu","raw_affiliation_strings":["Juntendo University Graduate School of International Liberal Arts, Bunkyo-ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Juntendo University Graduate School of International Liberal Arts, Bunkyo-ku, Japan","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147313077","display_name":"Kaily Fujimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kaily Fujimoto","raw_affiliation_strings":["Juntendo University Graduate School of International Liberal Arts, Bunkyo-ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Juntendo University Graduate School of International Liberal Arts, Bunkyo-ku, Japan","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147332587","display_name":"Haruto Shintani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Haruto Shintani","raw_affiliation_strings":["Laboratory of Cell Biology, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5131213432","display_name":"Hiroshi Koide","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Koide","raw_affiliation_strings":["Laboratory of Molecular and Biochemical Research, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular and Biochemical Research, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071707360","display_name":"Youichi Katoh","orcid":"https://orcid.org/0009-0004-9548-0859","observed_orcids":["https://orcid.org/0009-0004-9548-0859"]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Youichi Katoh","raw_affiliation_strings":["Juntendo University Graduate School of International Liberal Arts, Bunkyo-ku, Japan; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan. Electronic address: katoyo@juntendo.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Juntendo University Graduate School of International Liberal Arts, Bunkyo-ku, Japan; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan. Electronic address: katoyo@juntendo.ac.jp","institution_ids":["https://openalex.org/I34077901"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071707360","https://openalex.org/A5101667588"],"corresponding_institution_ids":["https://openalex.org/I34077901"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":{"value":3750,"currency":"USD","value_usd":3750},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5171274,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"393","issue":"9","first_page":"105013","last_page":"105013"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tlr3","display_name":"TLR3","score":0.9449999928474426},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9300000071525574},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8709999918937683},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.8669999837875366},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.906000018119812},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.9480000138282776},{"id":"https://openalex.org/keywords/endotoxemia","display_name":"endotoxemia","score":0.7689999938011169},{"id":"https://openalex.org/keywords/poly-i-c","display_name":"poly(I:C)","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tlr4","display_name":"TLR4","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tlr7-8","display_name":"TLR7/8","score":0.7179999947547913},{"id":"https://openalex.org/keywords/tlr9","display_name":"TLR9","score":0.9729999899864197},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7400000095367432},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9980000257492065},{"id":"https://openalex.org/keywords/endotoxin-tolerance","display_name":"endotoxin tolerance","score":0.5920000076293945},{"id":"https://openalex.org/keywords/anticancer-drug-toxicity","display_name":"anticancer drug toxicity","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2776070231","wikidata":"https://www.wikidata.org/wiki/Q14914098","display_name":"TLR4","level":3,"score":0.6646000146865845},{"id":"https://openalex.org/C2778420691","wikidata":"https://www.wikidata.org/wiki/Q14866230","display_name":"TLR3","level":5,"score":0.642799973487854},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5957000255584717},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.5892999768257141},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.5349000096321106},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.527400016784668},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5027999877929688},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48559999465942383},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.4745999872684479},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.41999998688697815},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.41609999537467957},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.39340001344680786},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.39079999923706055},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36480000615119934},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C2781363766","wikidata":"https://www.wikidata.org/wiki/Q7251505","display_name":"Protein synthesis inhibitor","level":4,"score":0.3440999984741211},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.3346000015735626},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3305000066757202},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3183000087738037},{"id":"https://openalex.org/C132149769","wikidata":"https://www.wikidata.org/wiki/Q899651","display_name":"Mitogen-activated protein kinase","level":3,"score":0.31200000643730164},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.31119999289512634},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.2816999852657318},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.27950000762939453},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.26350000500679016},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.25929999351501465},{"id":"https://openalex.org/C2779836521","wikidata":"https://www.wikidata.org/wiki/Q14914081","display_name":"TLR7","level":5,"score":0.25929999351501465}],"mesh":[{"descriptor_ui":"D000097912","descriptor_name":"Toll-Like Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051196","descriptor_name":"Toll-Like Receptor 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051196","descriptor_name":"Toll-Like Receptor 3","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052247","descriptor_name":"Nitric Oxide Synthase Type II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jpet.2026.105013","doi":"https://doi.org/10.1016/j.jpet.2026.105013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpet.2026.105013","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:42700643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42700643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jpet.2026.105013","doi":"https://doi.org/10.1016/j.jpet.2026.105013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpet.2026.105013","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1608452792","display_name":"TLR\u30a2\u30b4\u30cb\u30b9\u30c8\u306e\u6297\u816b\u760d\u4f5c\u7528\u3092MEK\u963b\u5bb3\u85ac\u4f75\u7528\u3067\u4fc3\u9032\u3055\u305b\u308b","funder_award_id":"25K10094","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G5011380038","display_name":"Elucidation of mechanisms of cancer therapeutics-related cardiac dysfunction for cancer health promotion","funder_award_id":"25K03072","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1496457337","https://openalex.org/W1834782762","https://openalex.org/W1993197717","https://openalex.org/W2001192666","https://openalex.org/W2012992792","https://openalex.org/W2023402680","https://openalex.org/W2051061580","https://openalex.org/W2066847273","https://openalex.org/W2067677689","https://openalex.org/W2072878985","https://openalex.org/W2087694430","https://openalex.org/W2105699711","https://openalex.org/W2109388940","https://openalex.org/W2152392393","https://openalex.org/W2158998343","https://openalex.org/W2190558971","https://openalex.org/W2572603768","https://openalex.org/W2749589017","https://openalex.org/W2761809676","https://openalex.org/W2765277717","https://openalex.org/W2768999194","https://openalex.org/W2789665281","https://openalex.org/W2911442568","https://openalex.org/W3000003327","https://openalex.org/W3001432063","https://openalex.org/W3011301336","https://openalex.org/W3105908160","https://openalex.org/W3119000054","https://openalex.org/W3169139193","https://openalex.org/W3180099097","https://openalex.org/W3191915670","https://openalex.org/W3206785112","https://openalex.org/W4214925106","https://openalex.org/W4229024720","https://openalex.org/W4251626475","https://openalex.org/W4283777218","https://openalex.org/W4309409968","https://openalex.org/W4313030987","https://openalex.org/W4387616954","https://openalex.org/W4387780683","https://openalex.org/W4392797782","https://openalex.org/W4394989398"],"related_works":["https://openalex.org/W4387616954","https://openalex.org/W2024232356","https://openalex.org/W2022398608","https://openalex.org/W2120275497","https://openalex.org/W7098928879","https://openalex.org/W1969485765","https://openalex.org/W2336020536","https://openalex.org/W7095619224","https://openalex.org/W2160296782","https://openalex.org/W1909011356"],"abstract_inverted_index":{"Lipopolysaccharide":[0],"(LPS)":[1],"is":[2,23,55,115,233,240],"an":[3,48],"endotoxin":[4],"that":[5,47,218],"can":[6],"trigger":[7],"multiple":[8],"types":[9],"of":[10,18,35,50,97,111,118,177,221,245],"acute":[11],"organ":[12],"failure":[13],"by":[14,25,57,78,104,166,192,235,271,296],"increasing":[15],"the":[16,60,90,109,150,155,174,186,203,219,243],"production":[17,34,77,103,136,160,200,227,257,295],"nitric":[19,255,293],"oxide":[20,256,294],"(NO),":[21],"which":[22,54,81,239],"synthesized":[24],"inducible":[26],"NO":[27,68,76,102,135,159,179,199,226],"synthase":[28],"(iNOS)":[29],"in":[30,63,108,137,152,158,182,206,228,258,274,300],"macrophages":[31,121,208],"through":[32,66,124],"increased":[33,59,131,254],"tumor":[36,275],"necrosis":[37,276],"factor":[38],"(TNF)-\u03b1,":[39],"interferon":[40,211],"gamma,":[41],"and":[42,120,134,180,198,213],"interleukin-12.":[43,214],"We":[44],"have":[45],"reported":[46],"inhibitor":[49,107,130,171,253],"MAPK/ERK":[51,251,297],"kinase":[52,252,298],"(MEK),":[53],"activated":[56],"LPS,":[58],"mortality":[61],"rate":[62],"LPS-treated":[64],"mice":[65,183,229,301],"enhanced":[67],"production.":[69,247,278],"However,":[70],"a":[71,105,116,272,287],"strategy":[72,289],"to":[73,163,224,286,290],"prevent":[74,291],"lethal":[75,292],"MEK":[79,106,129,170,222],"inhibitors,":[80],"are":[82],"used":[83],"as":[84],"anticancer":[85],"agents,":[86],"remains":[87],"unclear.":[88],"In":[89],"present":[91],"study,":[92],"we":[93],"examined":[94],"whether":[95],"prestimulation":[96],"Toll-like":[98,263,280],"receptors":[99],"(TLRs)":[100],"influences":[101],"presence":[110],"LPS":[112,114,193,232],"because":[113],"ligand":[117],"TLR4":[119],"acquire":[122],"tolerance":[123],"repeated":[125],"TLR":[126],"stimulation.":[127,168],"The":[128,169],"iNOS":[132,153,196],"expression":[133,197],"LPS-stimulated":[138],"mouse":[139,207],"macrophages.":[140],"While":[141],"pretreatment":[142],"with":[143,185,210,231,242,303],"TLR3,":[144],"TLR7/8,":[145],"or":[146],"TLR9":[147],"agonists":[148],"abolished":[149,234,267],"increase":[151,157,225],"expression,":[154],"subsequent":[156],"was":[161],"confirmed":[162],"be":[164],"suppressed":[165,173],"TLR3":[167,187,237],"also":[172],"serum":[175],"levels":[176],"both":[178],"TNF-\u03b1":[181,204,246],"pretreated":[184],"agonist":[188],"poly":[189],"I:C":[190],"followed":[191],"administration.":[194],"Both":[195],"depended":[201],"on":[202],"concentration":[205],"treated":[209,230,302],"gamma":[212],"These":[215],"results":[216],"suggest":[217],"ability":[220],"inhibitors":[223,299],"prior":[236,262],"stimulation,":[238],"associated":[241],"suppression":[244],"SIGNIFICANCE":[248],"STATEMENT:":[249],"A":[250],"lipopolysaccharide-treated":[259],"mice;":[260],"however,":[261],"receptor":[264,281],"3":[265,282],"stimulation":[266,283],"this":[268],"effect,":[269],"accompanied":[270],"reduction":[273],"factor-\u03b1":[277],"Prior":[279],"may":[284],"contribute":[285],"potential":[288],"lipopolysaccharide.":[304]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2026-08-18T00:00:00"}